Subscribe
About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: CMSC 2023

Novel approach to MS therapeutics: anti-CD40L

June 21, 2023

Selected highlights from CMSC 2023

June 6, 2023

Browse by Topic

MS (395)
AD (85)
PD (77)
COVID-19 (58)
BIOMARKERS IN MS (45)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)

EPILEPSY (33)
SCHIZOPHRENIA (25)
MIGRAINE (25)
STROKE (22)
Library (16)
CLINICAL CASES IN MS (12)
ECTRIMS 2015 (12)
AAN 2015 (11)
DEMENTIA (10)
ECTRIMS 2021 (10)
ECTRIMS 2014 (10)
AAN 2013 (9)
ECTRIMS 2018 (9)
AAN 2014 (9)
MS SEQUENCING (9)
ECTRIMS 2013 (9)
ECTRIMS 2019 (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (6)
ECTRIMS 2022 (6)
AAN 2021 (6)
AAN 2019 (6)
CHARCOT 2013 (6)
ECTRIMS 2024 (6)
AAN 2022 (5)
BIPOLAR (5)
ECTRIMS 2016 (5)
CCSVI (5)
ANXIETY (5)
AAN 2024 (5)
AAN 2023 (4)
BPD (4)
EAN 2015 (4)
NeuroSound (4)
EAN 2024 (3)
EAN 2022 (3)
PAIN (3)
AAN 2017 (3)
ENS 2013 (3)
AAN 2020 (3)
EAN 2023 (3)
ECTRIMS-ACTRIMS 2023 (3)
EAN 2020 (2)
CMSC 2023 (2)
ACTRIMS Forum 2024 (2)
NEW DRUGS (2)
SLEEP (2)
AAN 2018 (2)
APA 2014 (2)
SPECIAL REPORT (2)
TSC (1)
APA 2016 (1)
NEWS IN BRIEF (1)
AAN 2016 (1)
ECTRIMS (1)
ACTRIMS 2023 (1)
EAN (1)
LGS (1)
ALS (1)
SEIZURE (1)
EAN 2019 (1)
LUMBAR PUNCTURE (1)
Dravet syndrome (1)
CIDP (1)
CONCUSSION (1)
EAN 2021 (1)
ADDICTION (1)
GUIDELINES (1)
ACTRIMS 2022 (1)
INSOMNIA (1)
hATTR (1)
WEST NILE (1)
ECTRIMS 2020 (0)
BIOMARKERS (0)
EAN 2016 (0)
AAN (0)

View all Topics

Popular Posts

McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
ECTRIMS 2024 HIGHLIGHTS – THURSDAY, SEPTEMBER 19, 2024 posted on September 19, 2024

Copyright 2024 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions